JMP Securities Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR) Jan 24, 2025 05:18AM
Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares Sep 16, 2022 01:00PM
Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock Sep 14, 2022 07:04AM
Larimar Therapeutics Announces $70 Million Underwritten Offering Sep 14, 2022 07:04AM
Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference Jun 11, 2021 07:00AM


May 21, 2021 09:19AM Larimar Therapeutics (LRMR) Announces $95 Million Private Placement Financing of Common Stock, Warrants
May 21, 2021 09:18AM Larimar Therapeutics Announces $95 Million Private Placement Financing
May 11, 2021 01:45PM Larimar Therapeutics (LRMR) PT Raised to $43 at JMP Securities, Following Clinical Business Update
Feb 10, 2021 05:00AM UPDATE: JMP Securities Starts Larimar Therapeutics (LRMR) at Market Outperform